Skip to content

Clinical trials

Phase 1 Hypersensitivity trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Phase: Phase 1 Country / region: Canada Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20111
20181
20211
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergy Therapeutics3
Dr. George Luciuk2
Aquestive Therapeutics1
Jasper Therapeutics, Inc.1
Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division1
McNeil AB1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity10
Hypersensitivity, Immediate6
Anaphylaxis2
Asthma2
Bronchial Diseases1
Chronic Disease1
Immune System Diseases1
Lung Diseases1
Lung Diseases, Obstructive1
Respiratory Hypersensitivity1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.